Skip to main content

Hemoglobinopathy clinical trials at UCSF

2 in progress, 1 open to eligible people

Hemoglobinopathy includes genetic conditions that affect hemoglobin in the blood. At UCSF, a clinical trial is underway to explore stem cell transplants for those with transfusion-dependent beta thalassemia. Researchers examine if this approach is safe and works well.

Showing trials for

Last updated: